These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38128642)

  • 1. Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.
    Ferreira JP; Neves JS; Saraiva F
    J Card Fail; 2024 Feb; 30(2):418-420. PubMed ID: 38128642
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity in Early Life: Its Causes, Prevention and Risks in Later Life.
    Sauer P
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risks in childhood in Hungary.
    Barna M; Horvàth K; Bálint M; Antal M
    Forum Nutr; 2003; 56():247-9. PubMed ID: 15806884
    [No Abstract]   [Full Text] [Related]  

  • 4. Nutrition, obesity, diabetes, and cardiovascular outcomes: a deadly association.
    Lüscher TF
    Eur Heart J; 2020 Jul; 41(28):2603-2607. PubMed ID: 33216914
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
    Mensah GA; Mokdad AH; Ford E; Narayan KM; Giles WH; Vinicor F; Deedwania PC
    Cardiol Clin; 2004 Nov; 22(4):485-504. PubMed ID: 15501618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 7. Rethinking our approach to the obese patient: time to create the obesity treatment score.
    Mechanick JI; Apovian CM
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):339-40. PubMed ID: 22892868
    [No Abstract]   [Full Text] [Related]  

  • 8. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.
    Malik VS; Popkin BM; Bray GA; Després JP; Hu FB
    Circulation; 2010 Mar; 121(11):1356-64. PubMed ID: 20308626
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To be obese--does it matter if you are metabolically healthy?
    Karelis AD
    Nat Rev Endocrinol; 2011 Oct; 7(12):699-700. PubMed ID: 22009160
    [No Abstract]   [Full Text] [Related]  

  • 11. The domino effect: obesity, type 2 diabetes and cardiovascular disease.
    Green V
    Br J Community Nurs; 2005 Aug; 10(8):358-61. PubMed ID: 16116394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].
    Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA
    Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
    Scherer PE; Hill JA
    Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: Influence of different surgical procedures.
    Wei JH; Chou RH; Huang PH; Lee WJ; Chen SC; Lin SJ
    Surg Obes Relat Dis; 2018 Dec; 14(12):1832-1840. PubMed ID: 30473417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cardiovascular disease in young women overlooked?
    Rodriguez F; Foody JM
    Womens Health (Lond); 2013 May; 9(3):213-5. PubMed ID: 23638775
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.
    Prendergast C; Gidding SS
    Curr Diab Rep; 2014 Feb; 14(2):454. PubMed ID: 24402326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide spread of lifestyle diseases and its importance for cardiovascular events.
    Erdmann E
    Drugs Today (Barc); 2006 Dec; 42 Suppl C():5-8. PubMed ID: 17245475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.